Hard to compare complexity of Biotron assays to Immuron etc. along with taking into account 6 months of treatment plus several weeks follow-up post-dosing. I don't know the detail around Immuron trials however Biotron are analysing three very complex, data-heavy Phase 2 trials all at once.
Hard to compare complexity of Biotron assays to Immuron etc....
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.5¢ |
Change
-0.003(5.17%) |
Mkt cap ! $49.62M | |||
| Open | High | Low | Value | Volume |
| 5.8¢ | 5.8¢ | 5.4¢ | $41.34K | 730.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5797 | 5.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.5¢ | 20140 | 1 |
View Market Depth
| Last trade - 16.10pm 10/05/2024 (20 minute delay) ? |
|
|||||
|
Last
5.4¢ |
Change
-0.003 ( 6.90 %) |
||||
| Open | High | Low | Volume | ||
| 5.9¢ | 5.9¢ | 5.3¢ | 119512 | ||
| Last updated 15.48pm 10/05/2024 ? | |||||
| BIT (ASX) Chart |